Publications by authors named "Charles B Slonim"

Claim this Profile
S
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.
David L Wirta, Michael S Korenfeld, Shane Foster, Robert Smyth-Medina, Jason Bacharach, Charles B Slonim

Clin Ophthalmol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.
Jason Bacharach, David L Wirta, Robert Smyth-Medina, Michael S Korenfeld, Shane R Kannarr, Charles B Slonim

Clin Ophthalmol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial.
Paul M Karpecki, Shane A Foster, Stephen M Montaquila, Shane R Kannarr, Charles B Slonim

Optom Vis Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.
Jay S Pepose, Paul J Hartman, Harvey B DuBiner, Marc A Abrams, Robert J Smyth-Medina, Charles B Slonim

Clin Ophthalmol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials.
Charles B Slonim, Shane Foster, Mark Jaros, Shane R Kannarr, Michael S Korenfeld

JAMA Ophthalmol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.
John D Sheppard, Eric D Donnenfeld, Edward J Holland, Charles B Slonim, Renée Solomon

Eye Contact Lens· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of intranasal steroids to intraocular pressure.
Joseph Bergmann, Matthew T Witmer, Charles B Slonim

Curr Allergy Asthma Rep· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis.
Haroon Ilyas, Charles B Slonim, Guy R Braswell, John R Favetta, Melvin Schulman

Eye Contact Lens· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The correction of astigmatism with soft contact lenses.
Clarence H Russell, Charles B Slonim

Ophthalmol Clin North Am· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis